Form 4 for LFMD LifeMD, Inc.
Accepted 2025-04-02 00:00:00 ET · period of report 2025-03-31 · accession 0000912282-25-000361 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-02 | 2025-03-31 | LFMD | Benathen Marc David | CFO | A - Grant | $0.00 | +75.0K | 464.6K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-31 | A | A | 75,000 | $0.00 | 464,554 | D | — | — | (F1) Represents grant of performance stock which vested on March 31, 2025. |